Evidence map›Paper›PMID 39195219›Full record

ArticleCells2024

Complement Component C5a and Fungal Pathogen Induce Diverse Responses through Crosstalk between Transient Receptor Potential Channel (TRPs) Subtypes in Human Conjunctival Epithelial Cells.

Loreena Rech, Tina Dietrich-Ntoukas, Peter S Reinach, Tobias Brockmann, Uwe Pleyer, Stefan Mergler

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Loreena RechDepartment of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Tina Dietrich-NtoukasDepartment of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0002-9041-2249
Peter S ReinachSchool of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325015, China.ORCID 0000-0002-3494-4523
Tobias BrockmannDepartment of Ophthalmology, Universitätsmedizin Rostock, 18057 Rostock, Germany.ORCID 0000-0001-6939-1159
Uwe PleyerDepartment of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0002-5569-1473
Stefan MerglerDepartment of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0001-8608-648X

Funding

Deutsche Forschungsgemeinschaft ME 1706/18-1Sonnenfeld-Stiftung (Berlin, Germany) N.N.
6 · The paper itself

Abstract

The conjunctiva has immune-responsive properties to protect the eye from infections. Its innate immune system reacts against external pathogens, such as fungi. The complement factor C5a is an important contributor to the initial immune response. It is known that activation of transient-receptor-potential-vanilloid 1 (TRPV1) and TRP-melastatin 8 (TRPM8) channels is involved in different immune reactions and inflammation in the human body. The aim of this study was to determine if C5a and

Indexed as

CalciumComplement C5aConjunctivaEpithelial CellsCalcium SignalingHumansTransient Receptor Potential ChannelsTRPV Cation ChannelsCalciumComplement C5aTransient Receptor Potential ChannelsTRPV Cation ChannelsCa2+ signalingcomplement factor C5aconjunctival epithelial cellsfungal pathogentransient receptor potential channel melastatin 8transient receptor potential channel vanilloid 1

Identifiers

PMID39195219
PMCPMC11352353

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.